Evidence map›Paper›PMID 36307156›Full record

ArticleBMJ open2022

Recruitment

Zhen Wang, Bo Wang, Wenxi Xia, Peng Wang, Guopeng Liang, Jian Dong Mei, Yong-Gang Zhang, Kang Yan

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zhen WangDepartment of Respiratory Care, Sichuan University West China Hospital, Chengdu, Sichuan, China.ORCID 0000-0002-4383-2515
Bo WangDepartment of Critical Care Medicine, Sichuan University West China Hospital, Chengdu, Sichuan, China wchicu@126.com.ORCID 0000-0003-1135-2530
Wenxi XiaDepartment of Respiratory Care, Sichuan University West China Hospital, Chengdu, Sichuan, China.
Peng WangDepartment of Respiratory Care, Sichuan University, Chengdu, Sichuan, China.
Guopeng LiangDepartment of Critical Care Medicine, Sichuan University West China Hospital, Chengdu, Sichuan, China.
Jian Dong MeiDepartment of Thoracic Surgery, Sichuan University, Chengdu, Sichuan, China.
Yong-Gang ZhangDepartment of Periodical Press and National Clinical Research Center for Geriatrics, West China Hospital, Chengdu, Sichuan, China.
Kang YanDepartment of Critical Care Medicine, Sichuan University West China Medical Center, Chengdu, Sichuan, China.ORCID 0000-0002-5715-3900
Sichuan University · CNWest China Medical Center of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe incidence of postoperative pulmonary complications (PPCs) following thoracic surgery is high, which increases the mortality rate, prolongs the length of hospital stay and increases medical costs. Some studies have confirmed that preoperative risk assessment, intraoperative anaesthesia methods and intraoperative mechanical ventilation strategies, including recruitment manoeuvres (RMs), can reduce the incidence of PPCs. Despite these improved strategies, the incidence of PPCs remains high. However, mechanical ventilation strategies have not been studied in the postoperative period. METHODS AND ANALYSIS: We assume that RM during mechanical ventilation with sequential high-flow nasal oxygen therapy (HFNO) after extubation can maintain the opening of the postoperative alveoli and ultimately reduce the incidence of PPCs after thoracic surgery. We will include thoracic surgery patients and divide them into the RM with sequential HFNO group and the control group. They will be given RMs and sequential HFNO or be given conventional treatment. The sample size is 654 adult patients (327 per group) undergone thoracic surgery and presenting to the intensive care unit. ETHICS AND DISSEMINATION: This study was approved by the Biomedical Research Ethics Committee of West China Hospital of Sichuan University (REC2019-730). It is expected that this study will lead to a randomised controlled trial. We assume that the findings will provide more evidence about PPCs and improve the management of patients undergone thoracic surgery. TRIAL REGISTRATION NUMBER: ChiCTR2100046356.

Indexed as

Respiration, ArtificialThoracic SurgeryAdultAirway ExtubationHumansOxygenPostoperative ComplicationsPostoperative PeriodProspective StudiesRandomized Controlled Trials as TopicOxygenAdult anaesthesiaAdult intensive & critical careSURGERYThoracic surgery

Identifiers

PMID36307156
PMCPMC9621193
OpenAlexW4307713691

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.